
Veeva To Present At Upcoming Investor Conference
PLEASANTON, Calif., Jan. 13, 2025 /PRNewswire/ --
Veeva Systems (NYSE: VEEV ) today announced participation in the following investor conference:
-
27th Annual Needham Growth Conference.
Brian Van Wagener, CFO, and
Paul Shawah, EVP Strategy, will present on Thursday, January 16, 2025, at 1:30 p.m. Eastern Time.
The above presentation will be webcast. LINK to the live and archived webcast will be available on Veeva's investor relations website at .
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit
veeva .
Veeva uses its aria-invalid="true" href="" rel="nofollow" veev
website as a means of disclosing material non-public information, announcing upcoming investor conferences, and for complying with its disclosure obligations under Regulation FD. Accordingly, you should monitor Veeva's investor relations website in addition to following its press releases, SEC filings, and public conference calls and webcasts.
Investor Relations Contact:
Gunnar Hansen
Veeva Systems Inc.
267-460-5839
[email protected]
Media Contact:
Maria Scurry
Veeva Systems Inc.
781-366-7617
[email protected]
SOURCE Veeva Systems
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
No comment